Emergent BioSolutions (EBS) PT Lowered to $12 at H.C. Wainwright

March 9, 2026 6:50 AM

H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on Emergent BioSolutions (NYSE: EBS) to $12.00 (from $15.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found